Related Experiment Videos
[Clinical and experimental studies on muscle contracture]
Nihon Seikeigeka Gakkai Zasshi
|February 1, 1983
Summary
Muscle contracture etiology remains challenging. Intramuscular injections, like chloramphenicol, can cause irreversible muscle damage and fibrosis, contributing to contracture development.
Area of Science:
- Orthopedics
- Muscle Physiology
- Pharmacology
Context:
- Muscle contracture etiology, diagnosis, and treatment present ongoing clinical challenges.
- Understanding the impact of pharmaceutical interventions on muscle tissue is crucial for patient care.
- Existing diagnostic methods for conditions like quadriceps contracture require careful interpretation.
Purpose:
- To investigate the clinical diagnosis and treatment of muscle contracture.
- To experimentally determine the effects of specific intramuscular drug injections on muscle fiber integrity.
- To elucidate the potential etiological link between drug-induced muscle lesions and contracture formation.
Summary:
- Clinical observations noted variability in diagnosing quadriceps contracture and associated pain in adult deltoid contracture cases.
- Experimental administration of chloramphenicol solution via intramuscular injection in rabbits induced significant muscle lesions, including fibrosis and reduced phosphorylase activity, one year post-injection.
- These findings suggest that intramuscular injections can lead to irreversible muscle damage, identified as a primary etiological factor in muscle contracture.
Impact:
- Highlights the need for cautious interpretation of diagnostic signs like the buttock elevation phenomenon.
- Identifies intramuscular injections as a potential iatrogenic cause of muscle contracture.
- Provides experimental evidence linking drug-induced muscle fibrosis to the development of muscle contracture, informing clinical practice and drug administration guidelines.